Close Menu

NEW YORK (GenomeWeb) – The US Food and Drug Administration has granted 23andMe authorization to sell tests for 33 pharmacogenetic variants directly to consumers.

The reports, the FDA said, provide consumers information about genetic variants that may be associated with their ability to metabolize some medications and help inform discussions with their healthcare providers.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A new blood test might be able to detect the presence of some 50 cancers, according to New Scientist.

Undark looks into how coronavirus-related shutdowns are affecting field researchers.

In PNAS this week: strategies to design DNA oligonucleotide probes for bacteria, Vibrio cholerae evolution in Haiti, and more.

NPR reports that graduate students in the US are helping with SARS-CoV-2 testing.